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Corticosteroids can suppress both humoral and cellular immune responses in experi- 
mental animals such as the mouse, rat, and rabbit. Until recently, it was thought that 
corticosteroids acted in these systems by means of lymphoid cell destruction. Several 
recent reports, however, indicate that some of the cells involved in~ the induction and 
expression of immune responses are corticosteroid-resistant. This was first shown in 
the graft-vs.-host (GVH)  1 system by Warner (1) who demonstrated that the few cells 
which remained in the chicken thymus after cortisone treatment had virtually all the 
thymic GVH potential. Blomgren and Andersson have recently confirmed this in the 
mouse  (2).  These findings indicate that a  minority  (about 5%)  of  the  cells in  the 
thymus are corticosteroid-resistant  but are immunocompetent in the GVH system. The 
resistant cells appear to reside in the thymus medulla (3). The same pattern is true of 
the  spleen; about  75%  of  the  cells are corticosteroid-sensitive, while  the  resistant 
population contains all the spleen's GVH initiator potential (4). 
The circulating antibody response of mice to sheep erythrocytes (SRBC)  is 
markedly suppressed by corticosteroids given at about the same time as anti- 
gen (5). This response involves the interaction of at least two cells, one derived 
from the thymus and the other derived from bone marrow. Little is known about 
the effects of corticosteroids on the cooperating cells of this response. Compared 
with  normal  spleens,  spleens from  cortisone-treated donors have  a  decreased 
ability to transfer antibody-forming capacity to irradiated recipients (6). Since 
the spleen contains both marrow-derived and thymus-derived cells, such  data 
do  not  indicate  the  corticosteroid-sensitive step.  On  the  other  hand,  bone 
marrow cells (at least while in the marrow) are resistant to corticosteroids. This 
* Supported in part by the Medical Research Council of Canada and by grants AM-10145 
and TI AI 00013 from the National Institutes of Health, U.S. Public Health Service. 
Fellow of the Medical Research Council of Canada. 
1  Abbreviations used in this paper: AFC, antibody-forming cells; GVH,  graft-versus-host; 
MEM,  minimal essential medium;  PFC,  plaque-forming  cells;  PHA-phytohemagglutinin; 
SRBC, sheep erythrocytes; TL system, thymus-leukemia system. 
1026 J.  JOHN COHEN AND  HENRY N.  CLAMAN  1027 
was learned from experiments where bone marrow cells from donors given large 
doses of cortisone were able to cooperate well with normal thymus cells when 
transferred to syngeneic irradiated recipients and stimulated with SRBC anti- 
gen (6). We undertook the present investigations to determine the hydrocorti- 
sone sensitivity of the thymus component in this system and the nature of the 
corticosteroid sensitivity of spleen. 
Materials and Methods 
Animals.--Male LAF1 mice, aged 8-18 wk, were obtained from Jackson Laboratories, Bar 
Harbor, Maine. All mice in any one experiment were born on the same day and housed to- 
gether in groups of six. Drinking water contained 0.02% sodium hypochlorite. 
Hydrocortisone Treatment.--Some donors were given  2.5  mg  of  hydrocortisone  acetate 
suspension (Cortril, Chas. Pfizer & Co., Inc., New York) intraperitoneally 2 days before their 
tissues were used in transfer. Control donors received a similar volume of the Cortril vehicle. 
Irradiation.--Recipients received 1000 R in 10 rain at a distance of 60 cm from an Atomic 
Energy of Canada Ltd. s°Co source. 
Cell Preparations and Tranffer.--Single cell suspensions of spleen, femoral bone marrow, 
and thymus were prepared  as  described previously  (4). Thymuses  from  hydrocortisone- 
treated donors were removed under 4 X loupe magnification to avoid taking adjacent lymph 
nodes. Suspensions  in spinner-type minimal  essential medium (MEM) were centrifuged at 400 
g for  10 min and resuspended in MEM.  Nucleated cells were counted, and portions were 
mixed according to the protocol so that each recipient received the appropriate number of 
cells and 5 X  l0  s SRBC intravenously in a volume of 0.5 ml. Booster injections of antigen 
consisting of 0.5 ml of 10% SRBC were given intraperitoneally on day 4. On the 8th day after 
transfer, the recipients were killed by cervical dislocation and the spleens removed. 
Plaque-Forming Cell Detorminations.--Plaque-forming cells (PFC) in the recipient spleens 
were determined by the direct method of Jerne, Nordin, and Henry (7), modified in that 60 
mm Petri dishes were employed, and CO2 was omitted during incubation. 
RESULTS 
Immunocompetence  of Hydrocortisone-Resistant  Cells in the Thymus.--2  days 
after  administration of  2.5  mg  of  hydrocortisone  acetate  intraperitoneally, 
the thymuses of LAF1 mice contained 2.0-6.3%  of  the number of nucleated 
cells of normal thymuses. Normal thymus cells, equivalent in number to one 
thymus, were given intravenously to 20 irradiated recipients; 20 others were 
given one thymus-equivalent of cells from hydrocortisone-treated donors.  10 
mice in each group were also given l0  T bone marrow cells, and all mice were 
given SRBC intravenously. A booster of SRBC was given on day 4, and PFC 
were determined on day 8. Neither normal nor hydrocortisone-treated thymus 
alone transferred a  significant number of PFC, but they were equally effective 
in synergism with bone marrow (Table I). This experiment indicates that thy- 
mus "helper" cells are resistant to hydrocortisone. 
Resistance  of  Thymus  Cell  Proliferation  to  Hydrocortisone.--The  following 
experiment (Table II) was designed to determine whether thymus helper cells, 
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TABLE  I 
Helper Cell Activity of One Thymus-Equivalent  from Normal or llydrocortisone-Treated  Donors 
in Adoptive  Transfer of llumoral Immunity to Sheep Red Blood Cells* 
Experiment  Mice/  Thymus donors  Thymus cells  Marrow  group  transferred  cells  PF C/recipient  spleen 
transferred 
1  10  Normal  70 X  106  --  I0 (0-32);~ 
(Donors 8  10  Normal  70 X  106  107  794 (468-1346) 
wk old)  10  Hydrocortisone  1.4 >(  106  --  12 (0-38) 
10  Hydrocortisone  1.4 X  106  107  613  (224-1680) 
6  --  --  l0  T  16 (4-28) 
2  10  Normal  24 )<  106  --  51  (15-86) 
(Donors 18  10  Normal  24 X  l0  s  107  1020 (147-1893) 
wk old)  10  Hydrocortisone  1.2 X  106  --  25  (14-37) 
i0  Hydrocortisone  1.2  X  108  107  906 (213-1600) 
6  --  --  107  173  (50-280) 
* The equivalent of one thymus from normal LAFI donors, or donors treated with 2.5 mg 
of hydrocortisone acetate 2 days before, was transferred with or without normal bone marrow 
to  irradiated  (1000  R)  recipients  on day 0,  along with  SRBC.  SRBC  were  also  given  on 
day 4. 
Means and 95% confidence limits. 
TABLE  II 
Resistance to ttydrocortisone  of Antigen-Induced  Proliferation  of Thymus Cells* 
Group  Primary recipient  Secondary recipient 
(number of  mice)  Transferred  Hydrocorti-  Transferred  PFC/spleen 
Day 0  sone treatment  Day 5  Day 13 
A  (6)  Thymus  --  Primary spleen A  +  150  (90-212)* 
marrow +  SRBC 
B  (6)  Thymus +  SRBC  --  Primary spleen B  +  840  (240-1440) 
marrow +  SRBC 
C  (6)  Thymus +  SRBC  --6  hr;  +3  Primary spleen C  +  650  (254-1046) 
days  marrow +  SRBC 
D  (6)  Thymus +  SRBC  +24  hr;  +3  Primary spleen D  +  639  (255-1012) 
days  marrow +  SRBC 
* Six irradiated  (1000  R)  primary recipients were given 25  X  106 normal thymus cells 
with or without SRBC on day 0. One group which received thymus +  SRBC was given 2.5 
mg of hydrocortisone acetate 6 hr before transfer and on day 3; another such group was given 
hydrocortisone acetate 24 hr after transfer and on day 3.  On day 5,  spleens were removed 
and one spleen-equivalent transferred, with 107 bone marrow cells and SRBC, to each of six 
irradiated secondary recipients. A booster of SRBC was given on day 9, and PFC determined 
on day 13. 
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become sensitive when  stimulated by antigen to proliferate (8).  Normal thy- 
mus  cells were  "educated"  by transferring 25  )<  106  cells (equivalent in this 
experiment  to  one-half normal  thymus)  with  SRBC  to  irradiated syngeneic 
recipients. 5 days later, spleens were removed, single cell suspensions made, and 
107 normal bone marrow cells were added to the equivalent of one such spleen. 
TABLE III 
Reversal by Bone Marrow of the Suppressive  Effect of ttydrocortisone  on the Ability of Spleen 
to Transfer Adoptive Immunity to Sheep Red Blood Cells* 
Group 
(number  Spleen cells  Other cells  PFC/recipient spleen  Calculated 
of mice~  transferred  transferred  PFC/donor spleen 
A (6)  Normal 
(1.5 ×  106) 
B (6)  Normal 
(1.5 X  106) 
C (6)  Hvdrocorti- 
sone  - 
treated 
(1.5 X  106) 
D  (6)  Hydrocorti- 
sone- 
treated 
(1.5 X  106) 
E  (6)  Hydrocorti- 
sone- 
treated 
(1.5  X  10  6) 
--  250  (120-530) :~  10,500 
(4956-22,260) § 
107 Bone marrow  971  (550-1720)  40,782 
(22,932-72,576) 
--  139  (80-230)  2,780 
(1,660-4,680) 
107 Bone marrow  1347  (800-2400)  27,480 
(16,000-47,180) 
3.5  X  107 Thy-  180  (86-376)  3,600 
mus  (1,720-7,520) 
* 1.5 X  106 spleen cells from normal donors, or donors which had received 2.5 mg of hydro- 
cortisone acetate 2 days previously, were transferred with SRBC  to irradiated (1000 R) re- 
cipients. One group of recipients of normal spleen was also given 107 bone marrow cells. One 
group  of hydrocortisone-spleen recipients was given  107  bone marrow  ceils,  and  another 
group 3.5 X  107 normal thymus cells. All groups received SRBC. An SRBC booster was given 
on day 4, and PFC were determined on day 8. 
:~ Means and 95% confidence limits. 
§ The number of PFC/recipient spleen was multiplied by the inverse of the fraction of a 
donor spleen represented by 1.5 X  106 cells; this was 20 in the case of hydrocortisone spleen, 
and 42 for normal spleen. 
The mixture was transferred with SRBC to a second irradiated recipient; these 
mice were given boosters of SRBC  on day 9  (4 days after transfer). PFC were 
determined  8  days  after  the  second  transfer  (day  13).  Proliferation  of  the 
thymus  cells in  response  to  antigen  (in  the  first  recipient)  was  shown  by  a 
significant PFC response in the second recipient (group B); when antigen was 
omitted in the first recipient few PFC were ultimately obtained (group A). 
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of hydrocortisone acetate intraperitoneally either 6 hr before cell transfer (group 
C),  or 24 hr afterwards (group D). Both groups were given 2.5 mg of hydro- 
cortisone again 3 days after transfer, and their spleens were removed on day 5 
for injection, with normal bone marrow and SRBC, into secondary recipients. 
PFC determined 8 days later were not significantly different from those in the 
control educated group (groups C  and D  vs. group B); both groups in which 
hydrocortisone was present during the phase of thymus cell proliferation showed 
education. 
Locus  of Hydrocortisone Effect  on  the Adoptive  Response by  Spleen.--This 
experiment was designed to locate the hydrocortisone-sensitive population of 
spleen  cells  by  determining  what  cells  could  reconstitute  a  hydrocorti- 
sone-treated spleen. Normal spleen, and spleen from donors treated on day -2 
with  hydrocortisone acetate,  were  transferred  to  irradiated  recipients  with 
SRBC. The number of cells transferred in each case was 1.5 X  106, representing 
1/~  2 of a normal spleen or }/2o of a hydrocortisone spleen. PFC were determined, 
and  to  compare immunocompetence the  number  of PFC  that  theoretically 
would have been obtained if a  whole donor spleen had been transferred was 
calculated (Table III). Equal spleen cell numbers were transferred rather than 
organ equivalents, and small numbers of spleen cells were used, so that spleen- 
marrow synergism could be more easily demonstrated (9). 
As expected, spleen cells of mice treated with hydrocortisone were less able 
than normal spleen cells to produce PFC in irradiated recipients (group C vs. A). 
This immunosuppressive effect of hydrocortisone was in large measure reversed 
by transferring normal bone marrow with the hydrocortisone spleen (group D) ; 
addition of normal thymus was without effect (group E). The ability of hydro- 
cortisone spleen to transfer PFC was enhanced tenfold by bone nlarrow, while 
the number of PFC obtained with normal spleen cells was enhanced only four- 
fold by bone marrow. 
DISCUSSION 
There is a small population (about 5 %) of cells in the mouse th}mlus which 
survives treatment with 2.5 mg of hydrocortisone acetate (10). This population 
seems to contain all the hmnunocompetent cells in the thymus.  In terms of 
cell-mediated immunity, the GVH initiator cells of normal th3~nus have been 
found in the hydrocortisone-resistant population (2, 4), indicating that, by this 
criterion, the 95 %  of thymus cells that  are killed by hydrocortisone are not 
immunocompetent. The results presented above lead to a  similar  conclusion 
about thymus helper cells in the humoral immune response. One thymus from a 
hydrocortisone-treated donor induced as many antibody-forming cells (AFC) 
in normal bone marrow as did one normal thymus, although it contained only 
5 % as many cells. Thus, the active thymus helper cells are contained in the 5 % 
or less  of the  thymus nucleated cells  which  are  resistant  to hydrocortisone. 
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The response of thymic helper cells to antigen (education), which results in 
an expanded population of these cells  (12),  was also found to be resistant to 
hydrocortisone (Table II). Hydrocortisone was administered to one group of 
primary recipients before cell transfer, so that even the earliest events of lym- 
phocyte-antigen interaction in the recipient would take place in the presence 
of the  drug.  Since corticosteroids might affect the circulation of transferred 
lymphoid cells, we included another group which received hydrocortisone 24 hr 
after cell transfer, by which time homing is virtually completed (13).  Results 
in both groups were similar; hydrocortisone had little effect on thymus educa- 
tion. 
The  role  of  the  great majority of  thymus lymphocytes (those  which  are 
sensitive to hydrocortisone) is not established. It is probable that these cells, 
primarily situated in the cortex (3), are immunologically immature precursors 
of hydrocortisone-resistant medullary cells. Experiments using tritiated thymi- 
dine labeling have shown intense mitotic activity in the thymus cortex, and very 
much less in the medulla; as cortical cells divide, they appear to move into the 
medulla (14, 15). From these data, one might assume that hydrocortisone pref- 
erentially affects dividing cells, but our experiments with education for GVH 
(16) and helper activity in the antibody response (Table II) indicate that the 
situation is not that simple; in both these systems the proliferation of specific 
cells under antigenic stimulation (17)  is hydrocortisone resistant. We suggest 
that lymphoid cells possess or lack, depending on their stage of maturation, a 
surface hydrocortisone receptor whose presence is essential for the cytotoxic 
effect of hydrocortisone to be manifest. There is experimental evidence for such 
a receptor (18). 
There are also considerable experimental data which support the view that 
surface features change as thymic lymphocytes mature. The cells of the thymus 
medulla, but not those of the cortex,  are stimulated by phytohemagglutinin 
(PHA) (19), which probably involves binding of the mitogen to a surface recep- 
tor  (20).  Thymus-derived cells  in peripheral  lymphoid tissues are  also PHA 
stimu]able (21); thus, it appears that the ability to be stimulated by PHA is a 
marker for mature thymus cells. In a study of the thymus-leukemia (TL) sys- 
tem of thymus antigens, a small number of TL-negative cells were identified in 
the thymuses of TL-positive strains of mice (22). This minority contained most 
of the GVH initiators; thus, the cells expressing TL antigen were not immuno- 
competent. Schlesinger and Golakai have demonstrated that the TL-positive 
th)anus cells are also hydrocortisone sensitive (23).  Whether the TL-negative 
cells  tend to be located in the medulla has not been established. Taking all 
these data into account, we suggest that most thymic cortical lymphocytes are: 
rapidly dividing (14), corticosteroid sensitive (3), immunoincompetent (4, 16), 
TL positive in those mice possessing the TL antigen (23), unresponsive to PHA 
(19), and relatively poor in the expression of H-2 antigens (23). Thymic medul- 
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Spleen cells from mice treated with hydrocortisone were poor at transferring 
AFC to irradiated mice. This immunosuppressive effect of hydrocortisone could 
be on any of the three cell types known to be involved in humoral immune 
responses, and found in spleen: the macrophage (the in vivo counterpart of the 
adherent cell), the thymus-derived helper cell, or the AFC precursor. We con- 
sider the macrophage to be an unlikely candidate, since the irradiated recipient 
probably supplies an excess of these cells (24); more directly, cortisone treat- 
ment has been found not to affect the production of adherent cells active in in 
vitro antibody synthesis systems  ~ and peritoneal macrophages are  relatively 
unaffected by cortisone (25). 
Our data suggest that, in the spleen, the marrow-derived AFC precursor and 
not the helper cell is the cell sensitive to hydrocortisone, since the immuno- 
competence of hydrocortisolle-spleen can be restored by bone marrow and not 
by thymus, i.e., hydrocorfisone-spleen is deficient in AFC precursors relative 
to  normal  spleen.  Several other pieces  of evidence are  in  keeping with  this 
conclusion; another thymus-derived cell in the  spleen,  the GVH initiator,  is 
hydrocortisone resistant (4), and the mature GVH (2, 4)  and helper cells (11, 
and above)  of the  thymus itself are resistant.  In a  recent report, Andersson 
and Blomgren (11)  were unable to show an effect of cortisone on the adoptive 
transfer of humoral  immunity by spleen,  but they used  a  dose of cortisone 
which, in their mice, was not immunosuppressive. 
The maturation of the AFC with respect to corticosteroid sensitivity appears 
to be complex. The bone marrow serves as a reservoir of AFC precursors, and 
probably populates the  spleen and lymph nodes with these cells as  required 
(26). Levine and Claman have shown that, within the bone marrow itself, the 
AFC  precursor is resistant  to high doses of cortisone (6). By the time these 
cells have populated the spleen,  they have become relatively hydrocortisone 
sensitive (see above). The mature AFC, however, is hydrocortisone resistantJ 
A considerable amount of further evidence is required to relate the changes in 
corticosteroid sensitivity of the  AFC  precursor to immunocompetence. This 
cell is much more difficult than the thymus cell to study because of the relative 
paucity of surface features as yet identified, and because functional tests that 
do not depend on the antigen-induced production of antibody, similar for ex- 
ample to PHA stimulation, are not available. 
SI~M~L~RY 
Corticosteroids suppress  the humoral  antibody response of mice  to  sheep 
erythrocytes. This response depends on interactions between thymus-derived 
helper cells and bone marrow-derived antibody-forming cell precursors (AFC 
precursors). Previous experiments had  shown that  spleen cells (a mixture of 
thymus-derived  and  marrow-derived  cells)  were  sensitive  to  corticosteroids 
2  Talmage, D. W., and J. Radovich. Unpublished results. 
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while AFC precursors in the bone marrow were resistant.  The present  experi- 
ments showed that the thymus of a mouse given 2.5 mg of hydrocortisone ace- 
tate,  although  containing only about 5 %  of the number  of cells  of a  normal 
thymus, was as effective as a normal thymus in cooperating with bone marrow 
when transferred to irradiated syngeneic mice and stimulated with SRBC. The 
proliferative  response  of thymus helper  cells  to  SRBC  was  also  resistant  to 
hydrocortisone. 
In this  context,  the majority  of thymic cells  are  in the  cortex,  are  rapidly 
dividing,  are  sensitive  to  corticosteroids  and  are  not  immunocompetent.  A 
small number of thymic cells, probably located in the medulla,  are resistant to 
corticosteroids, but are immunocompetent since they can serve as helper cells. 
The  hydrocortisone-sensitive  phase  of  the  splenic  response  to  SRBC  was 
found to be the bone marrow-derived AFC precursor since spleens from hydro- 
cortisone-treated  donors  had  immunocompetence  restored  by  normal  bone 
marrow but not by normal thymus cells. 
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